Thomas Bradshaw

clinical stage parkinsons disease treatment with support from major Parkinsons Foundations

Facebook Twitter LinkedIn

Interim financing for clinical stage biotech with allowed US Patent, human proof of principle data (Thomas Jefferson Medical School -published results and Neuronasal human pilot results)- planned Phase 1 trial.  Highly experienced team.  Deck available. Seeking $3 million bridge convertible debt.  Expect no further dilution because of foundation support 

Ready to Ask For Funding for your company?

Post a Funding Request

Thomas Bradshaw is no longer seeking funding.